Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases

Anticancer Research

Volumn 22, Issue 1 A, 2002, Pages 421-425

  Thijssen, Myriam A M A ^a   Swinkels, Dorine W ^a   Ruers, Theo J M ^a   De Kok, Jacques B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Circulating tumour DNA; Real time quantitative PCR; Tumour diagnostics

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; COLORECTAL CANCER; DIAGNOSTIC VALUE; FLUOROMETRY; FOLLOW UP; HUMAN; HUMAN TISSUE; LIVER METASTASIS; NUCLEOTIDE SEQUENCE; PLASMA; POLYMENOPHOREA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SERUM;

AGED; COLORECTAL NEOPLASMS; DNA, NEOPLASM; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036254964     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Surgical treatment of colorectal metastases to the liver
2. Liver resection for colorectal metastases
3. Colorectal tumours
4. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease
5. Free DNA in the serum of cancer patients and the effect of therapy
6. Isolation and characterization of DNA from the plasma of cancer patients
7. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours
8. Apoptosis in serum of patients with solid tumours
9. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients
10. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients
11. Clinical value of bile for the detection of mutant K-ras from colorectal liver metastases
12. Real time quantitative PCR
13. Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation
14. Free DNA in the serum of cancer patients and the effect of therapy
15. Recovery of nanogram quantities of DNA from plasma and quantitative measurement using labeling by nick translation
16. Use of real-time quantitative PCR to compare DNA isolation methods
17. Methods for extracting and amplifying genomic DNA isolated from frozen serum
18. Plasma DNA as cell death marker in elderly patients
19. DNA of free and complexed origin in human plasma: Concentration and length distribution
20. DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells
21. Quantitation of blood plasma DNA as an index of in vivo cytotoxicity
22. Free DNA in serum and plasma from normal adults
23. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus
24. Molecular detection of genetic alterations in the serum of colorectal cancer patients
25. Microsatellite alterations in serum DNA of head and neck cancer patients
26. Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer
27. Decreased zeta chain expression and apoptosis in CD 3 peripheral blood T lymphocytes of patients with melanoma
28. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
29. Production and pro-apoptotic activity of soluble CD 95 ligand in pancreatic carcinoma
30. Nucleosomes in serum of patients with benign and malignant diseases
31. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor
32. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis
33. Detection of tumour DNA in serum of colorectal cancer patients